Voyager Therapeutics (VYGR) Research & Development (2014 - 2026)
Voyager Therapeutics (VYGR) reported Research & Development of $22.04 million for Q2 2026, down 29.6% from $31.33 million a year earlier and down 10.4% from the prior quarter.
Powered by 
Analysis
Voyager Therapeutics (VYGR) Research & Development (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Voyager Therapeutics' Research & Development came in at $118.46 million, down 7.9% year-over-year; for FY2025, it came in at $134.67 million, up 5.7% from FY2024.
- Research & Development has increased for three consecutive years, with a five-year compound annual growth rate of 4.4% (FY2020 to FY2025).
- By year, Research & Development came in at $127.37 million in FY2024 (+38.2%), $92.17 million in FY2023 (+51.7%), $60.76 million in FY2022 (-17.6%) and $73.79 million in FY2021 (-32.2%).
- The Q2 2026 figure ranks as the lowest quarterly Research & Development since Q2 2023.
- Year over year, Research & Development gained in five of the last eight quarters, with growth averaging 3.8%.
- The high point for year-over-year Research & Development in five years was Q4 2023 (growth of 77.0%); the low point was Q4 2021 (a decline of 36.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $24.6 million (Q1 2026), $35.95 million (Q4 2025) and $35.87 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Voyager Therapeutics | 161.76 Mn | -501.43 Mn | - | 22.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.04 Mn |
| Mar 31, 2026 | 24.60 Mn |
| Dec 31, 2025 | 35.95 Mn |
| Sep 30, 2025 | 35.87 Mn |
| Jun 30, 2025 | 31.33 Mn |
| Mar 31, 2025 | 31.53 Mn |
| Dec 31, 2024 | 35.58 Mn |
| Sep 30, 2024 | 30.24 Mn |
| Jun 30, 2024 | 34.45 Mn |
| Mar 31, 2024 | 27.09 Mn |
| Dec 31, 2023 | 25.76 Mn |
| Sep 30, 2023 | 25.86 Mn |
| Jun 30, 2023 | 21.99 Mn |
| Mar 31, 2023 | 18.57 Mn |
| Dec 31, 2022 | 14.55 Mn |
| Sep 30, 2022 | 19.34 Mn |
| Jun 30, 2022 | 12.53 Mn |
| Mar 31, 2022 | 14.35 Mn |
| Dec 31, 2021 | 14.02 Mn |
| Sep 30, 2021 | 17.91 Mn |
API Access
Voyager Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=VYGR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "VYGR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=VYGR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();